Cargando…
CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
Diffuse Large B Cell Lymphoma (DLBCL) is the most common form of blood cancer. Among the subtypes, the activated B-cell (ABC) subtype is typically more aggressive and associated with worse outcomes. However, the underlying mechanisms are not fully understood. In this study, we performed microarray a...
Autores principales: | Gong, Yuqi, Tong, Hongyan, Yu, Fang, Liu, Qi, Huang, Xianbo, Ren, Guoping, Fan, Zhongqin, Wang, Zhe, Zhao, Jing, Mao, Zhengrong, Zhang, Jing, Zhou, Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567943/ https://www.ncbi.nlm.nih.gov/pubmed/37684379 http://dx.doi.org/10.1007/s00277-023-05409-w |
Ejemplares similares
-
KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry
por: Gong, Yuqi, et al.
Publicado: (2022) -
NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma
por: Zhou, Lingna, et al.
Publicado: (2021) -
Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis
por: Bilajac, Esma, et al.
Publicado: (2022) -
Wilms’ tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90
por: Kuai, Yue, et al.
Publicado: (2018) -
Myostatin Promotes Osteoclastogenesis by Regulating Ccdc50 Gene Expression and RANKL-Induced NF-κB and MAPK Pathways
por: Zhi, Xin, et al.
Publicado: (2020)